Albendazole

Generic Name
Albendazole
Brand Names
Albenza
Drug Type
Small Molecule
Chemical Formula
C12H15N3O2S
CAS Number
54965-21-8
Unique Ingredient Identifier
F4216019LN
Background

A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)

Indication

For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

Associated Conditions
Hydatid disease of the Liver, Hydatid disease of the Lung, Hydatid disease of the Peritoneum, Neurocysticercosis
Associated Therapies
-
Clinical Trials
Related News

Deworming Against Tuberculosis

Not Applicable
Completed
Conditions
Tuberculosis
Interventions
Drug: Placebo
Drug: Albendazole
First Posted Date
2009-03-06
Last Posted Date
2013-08-29
Lead Sponsor
Linkoeping University
Target Recruit Count
140
Registration Number
NCT00857116
Locations
🇪🇹

University of Gondar, Gondar, Region 3, Ethiopia, Gondar, Ethiopia

Ivermectin Versus Albendazole for Chronic Strongyloidiasis

Phase 3
Completed
Conditions
Chronic Strongyloidiasis
Interventions
Drug: ivermectin
Drug: Albendazole
First Posted Date
2008-10-02
Last Posted Date
2017-09-07
Lead Sponsor
Mahidol University
Target Recruit Count
90
Registration Number
NCT00765024
Locations
🇹🇭

Siriraj Hospital, Bangkoknoi, Bangkok, Thailand

Treatment of Asymptomatic Toxocariasis With Albendazole in Children

Phase 3
Active, not recruiting
Conditions
Toxocariasis
Interventions
Drug: Placebo
Drug: Albendazole
First Posted Date
2008-09-19
Last Posted Date
2023-03-02
Lead Sponsor
Hospital de Niños R. Gutierrez de Buenos Aires
Target Recruit Count
45
Registration Number
NCT00755560
Locations
🇦🇷

Parasitology Division, Children's Hospital "R Gutierrez" of Buenos Aires, Buenos Aires, Argentina

Efficacy Albendazole and Levamisole Against STH on Unguja

Phase 4
Completed
Conditions
Ascariasis
Trichuriasis
Interventions
Drug: Levamisole
Drug: Albendazole
First Posted Date
2008-04-17
Last Posted Date
2008-04-17
Lead Sponsor
Natural History Museum, United Kingdom
Target Recruit Count
20
Registration Number
NCT00659997
Locations
🇹🇿

Helminth Control Laboratory Unguja, Stone Town, Tanzania

Effect of Albendazole Dose on Treatment of Lymphatic Filariasis

First Posted Date
2007-08-03
Last Posted Date
2015-08-31
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
40
Registration Number
NCT00511004
Locations
🇮🇳

Filariasis Chemotherapy Unit (FCU), T.D. Medical Hospital, Alleppey, Kerala, India

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

First Posted Date
2007-07-26
Last Posted Date
2014-11-20
Lead Sponsor
University of Washington
Target Recruit Count
948
Registration Number
NCT00507221
Locations
🇰🇪

Kenya Medical Research Institute, Nairobi, Kenya

Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)

First Posted Date
2007-02-28
Last Posted Date
2015-06-11
Lead Sponsor
Universidad Peruana Cayetano Heredia
Target Recruit Count
156
Registration Number
NCT00441285
Locations
🇵🇪

Universidad Peruana Cayetano Heredia, Lima, Peru

🇵🇪

Hospital Nacional Edgardo Rebagliati, Lima, Peru

🇵🇪

Hospital Nacional Cayetano Heredia, Lima, Peru

and more 2 locations

Relative Efficacy of Two Regimens of Ante-helminthic Treatment

Not Applicable
Completed
Conditions
Helminthiasis
First Posted Date
2006-08-23
Last Posted Date
2011-07-12
Lead Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Target Recruit Count
200
Registration Number
NCT00367627
Locations
🇧🇩

ICDDR,B: Centre for Health and Population Research, Dhaka, Bangladesh

Effect of Albendazole Dose on Clearance of Filarial Worms

Phase 2
Completed
Conditions
Lymphatic Filariasis
First Posted Date
2006-06-21
Last Posted Date
2017-07-02
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
1000
Registration Number
NCT00339417
Locations
🇲🇱

University of Bamako, Faculty of Medicine, Pharmacy and Odontostomatology, Bamako, Mali

Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

First Posted Date
2006-02-13
Last Posted Date
2017-02-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
110
Registration Number
NCT00290823
Locations
🇵🇪

Instituto Especializado en Ciencias Neurologicas, Lima, Peru

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy